Psilos Group
North America, New York, United States, New York
Description
Psilos has established itself as a successful healthcare investor and has demonstrated its ability to effectively identify and analyze
Investor Profile
Psilos Group has made 37 investments, with 0 in the past 12 months and 49% as lead.
Stage Focus
- Series B (32%)
- Series Unknown (24%)
- Series C (16%)
- Series A (16%)
- Series D (5%)
- Series E (5%)
Country Focus
- United States (97%)
- France (3%)
Industry Focus
- Health Care
- Medical
- Biotechnology
- Software
- Medical Device
- Hospital
- Information Technology
- Mhealth
- Pharmaceutical
- Manufacturing
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
'%3e%3cpath fill='%23012169' d='M0 0v30h60V0z'/%3e%3cpath stroke='%23fff' stroke-width='6' d='m0 0 60 30m0-30L0 30'/%3e%3cpath stroke='%23C8102E' stroke-width='4' d='m0 0 60 30m0-30L0 30' clip-path='url(%23b)'/%3e%3cpath stroke='%23fff' stroke-width='10' d='M30 0v30M0 15h60'/%3e%3cpath stroke='%23C8102E' stroke-width='6' d='M30 0v30M0 15h60'/%3e%3c/g%3e%3c/svg%3e)
